Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion model

Prostate

Volumn 73, Issue 13, 2013, Pages 1403-1412

  Ueda, Takashi ^a   Ito, Saya ^a   Shiraishi, Takumi ^a,b   Kulkarni, Prakash ^b,c   Ueno, Akihisa ^a   Nakagawa, Hideo ^a   Kimura, Yasunori ^a   Hongo, Fumiya ^a   Kamoi, Kazumi ^a   Kawauchi, Akihiro ^a   Miki, Tsuneharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

invasion; membrane protein; metastasis; PAX2; prostate cancer

Indexed keywords

MATRIGEL; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PAX2; TUMOR PROMOTER;

ARTICLE; CANCER MODEL; CELL INVASION; CONTROLLED STUDY; DNA MICROARRAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

INVASION; MEMBRANE PROTEIN; METASTASIS; PAX2; PROSTATE CANCER;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM METASTASIS; PAX2 TRANSCRIPTION FACTOR; PROSTATE; PROSTATIC NEOPLASMS; UP-REGULATION;

EID: 84882272839     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22687     Document Type: Article

References (31)

1. Takaha N, Okihara K, Kamoi K, Hongo F, Iwata T, Yano K, Ueda T, Takeuchi I, Yamada T, Kawauchi A, Miki T,. Feasibility of tri-weekly docetaxel-based chemotherapy for elderly patients (age 75 and older) with castration-resistant prostate cancer. Urol Int 2011; 87: 263-269.
2. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F,. EAU guidelines on prostate cancer. Eur Urol 2008; 53: 68-80.
3. Cavallaro U, Christofori G,. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-132.
4. Morris JPT, Wang SC, Hebrok M,. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 2010; 10: 683-695.
5. Robson EJ, He SJ, Eccles MR,. A PANorama of PAX genes in cancer and development. Nat Rev Cancer 2006; 6: 52-62.
6. Chen Q, DeGraff DJ, Sikes RA,. The developmental expression profile of PAX2 in the murine prostate. Prostate 2010; 70: 654-665.
7. Xu B, Hariharan A, Rakshit S, Dressler GR, Wellik DM,. The role of Pax2 in mouse prostate development. Prostate 2012; 72: 217-224.
8. Eccles MR, Schimmenti LA,. Renal-coloboma syndrome: A multi-system developmental disorder caused by PAX2 mutations. Clin Genet 1999; 56: 1-9.
9. Maulbecker CC, Gruss P,. The oncogenic potential of Pax genes. EMBO J 1993; 12: 2361-2367.
10. Daniel L, Lechevallier E, Giorgi R, Sichez H, Zattara-Cannoni H, Figarella-Branger D, Coulange C,. Pax-2 expression in adult renal tumors. Hum Pathol 2001; 32: 282-287.
11. Khoubehi B, Kessling AM, Adshead JM, Smith GL, Smith RD, Ogden CW,. Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J Urol 2001; 165: 2115-2120.
12. Akimoto C, Ueda T, Inoue K, Yamaoka I, Sakari M, Obara W, Fujioka T, Nagahara A, Nonomura N, Tsutsumi S, Aburatani H, Miki T, Matsumoto T, Kitagawa H, Kato S,. Testis-specific protein on Y chromosome (TSPY) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumors. Proc Natl Acad Sci USA 2010; 107: 19891-19896.
13. Bova GS, Fox WM, Epstein JI,. Methods of radical prostatectomy specimen processing: A novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod Pathol 1993; 6: 201-207.
14. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS,. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998; 58: 204-209.
15. Shiraishi T, Terada N, Zeng Y, Suyama T, Luo J, Trock B, Kulkarni P, Getzenberg RH,. Cancer/testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy. J Transl Med 2011; 9: 153.
16. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP,. LNCaP model of human prostatic carcinoma. Cancer Res 1983; 43: 1809-1818.
17. Mickey DD, Stone KR, Wunderli H, Mickey GH, Vollmer RT, Paulson DF,. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 1977; 37: 4049-4058.
18. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW,. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17: 16-23.
19. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR,. Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 2003; 22: 7989-7997.
20. McConnell MJ, Cunliffe HE, Chua LJ, Ward TA, Eccles MR,. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2. Oncogene 1997; 14: 2689-2700.
21. Doberstein K, Pfeilschifter J, Gutwein P,. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma. Carcinogenesis 2011; 32: 1713-1723.
22. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM,. A census of human transcription factors: Function, expression and evolution. Nat Rev Genet 2009; 10: 252-263.
23. Valastyan S, Weinberg RA,. Tumor metastasis: Molecular insights and evolving paradigms. Cell 2011; 147: 275-292.
24. Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M, Wu H,. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 2012; 72: 1878-1889.
25. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE,. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 2010; 16: 1414-1420.
26. Zwart W, Theodorou V, Kok M, Canisius S, Linn S, Carroll JS,. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. EMBO J 2011; 30: 4764-4776.
27. Cai Y, Brophy PD, Levitan I, Stifani S, Dressler GR,. Groucho suppresses Pax2 transactivation by inhibition of JNK-mediated phosphorylation. EMBO J 2003; 22: 5522-5529.
28. Patel SR, Kim D, Levitan I, Dressler GR,. The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev Cell 2007; 13: 580-592.
29. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, Schreiber SL, Mellor J, Kouzarides T,. Active genes are tri-methylated at K4 of histone H3. Nature 2002; 419: 407-411.
30. Brentani H, Caballero OL, Camargo AA, da Silva AM, da Silva WA, Jr., Dias Neto E, Grivet M, Gruber A, Guimaraes PE, Hide W, Iseli C, Jongeneel CV, Kelso J, Nagai MA, Ojopi EP, Osorio EC, Reis EM, Riggins GJ, Simpson AJ, de Souza S, Stevenson BJ, Strausberg RL, Tajara EH, Verjovski-Almeida S, Acencio ML, Bengtson MH, Bettoni F, Bodmer WF, Briones MR, Camargo LP, Cavenee W, Cerutti JM, Coelho Andrade Costa LE, dos Santos PC, Ramos Costa MC, da Silva IT, Estecio MR, Sa Ferreira K, Furnari FB, Faria M, Jr., Galante PA, Guimaraes GS, Holanda AJ, Kimura ET, Leerkes MR, Lu X, Maciel RM, Martins EA, Massirer KB, Melo AS, Mestriner CA, Miracca EC, Miranda LL, Nobrega FG, Oliveira PS, Paquola AC, Pandolfi JR, Campos Pardini MI, Passetti F, Quackenbush J, Schnabel B, Sogayar MC, Souza JE, Valentini SR, Zaiats AC, Amaral EJ, Arnaldi LA, de Araujo AG, de Bessa SA, Bicknell DC, Ribeiro de Camaro ME, Carraro DM, Carrer H, Carvalho AF, Colin C, Costa F, Curcio C, Guerreiro da Silva ID, Pereira da Silva N, Dellamano M, El-Dorry H, Espreafico EM, Scattone Ferreira AJ, Ayres Ferreira C, Fortes MA, Gama AH, Giannella-Neto D, Giannella ML, Giorgi RR, Goldman GH, Goldman MH, Hackel C, Ho PL, Kimura EM, Kowalski LP, Krieger JE, Leite LC, Lopes A, Luna AM, Mackay A, Mari SK, Marques AA, Martins WK, Montagnini A, Mourao Neto M, Nascimento AL, Neville AM, Nobrega MP, O'Hare MJ, Otsuka AY, Ruas de Melo AI, Paco-Larson ML, Guimaraes Pereira G, Pesquero JB, Pessoa JG, Rahal P, Rainho CA, Rodrigues V, Rogatto SR, Romano CM, Romeiro JG, Rossi BM, Rusticci M, Guerra de Sa R, Sant' Anna SC, Sarmazo ML, Silva TC, Soares FA, Sonati Mde F, de Freitas Sousa J, Queiroz D, Valente V, Vettore AL, Villanova FE, Zago MA, Zalcberg H,. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci USA 2003; 100: 13418-13423.
31. Segal E, Friedman N, Koller D, Regev A,. A module map showing conditional activity of expression modules in cancer. Nat Genet 2004; 36: 1090-1098.